Authors:
Morrow, M
White, J
Moughan, J
Owen, J
Pajack, T
Sylvester, J
Wilson, JF
Winchester, D
Citation: M. Morrow et al., Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma, J CL ONCOL, 19(8), 2001, pp. 2254-2262
Citation: M. Morrow et J. Sylvester, Quality in cancer care - Part II. The cancer program of the American College of Surgeons Commission on Cancer, CURR P CANC, 25(2), 2001, pp. 98-111
Authors:
Sylvester, J
Grimm, P
Blasko, J
Meier, R
Spiegel, J
Heaney, C
Cavanagh, W
Citation: J. Sylvester et al., The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States, UROLOGY, 58(2A), 2001, pp. 65-70
Citation: Dww. Newling et al., Osteoporosis due to androgen deprivation therapy in men with prostate cancer - Discussion, UROLOGY, 58(2A), 2001, pp. 106-107
Authors:
Sylvester, J
Liacini, A
Li, WQ
Dehnade, F
Zafarullah, M
Citation: J. Sylvester et al., Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappa B activities, MOLEC PHARM, 59(5), 2001, pp. 1196-1205
Citation: F. Debruyne et al., Three-dimensional ultrasound analyses of the prostate - Open discussion following Dr. Feleppa's presentation, MOL UROL, 4(3), 2000, pp. 141-141
Authors:
Sylvester, J
Blasko, JC
Grimm, PD
Meier, R
Cavanagh, W
Citation: J. Sylvester et al., Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis, MOL UROL, 4(3), 2000, pp. 155-159
Authors:
Sylvester, J",Stone,"Bostwick, D
Fair, W
Garzotto, M
Garnick, M
Moul, J
D'Amico, A
Citation: D. Sylvester, J",stone,"bostwick et al., Effects of neoadjuvant hormonal therapy on prostate biopsy results after I-125 and Pd-103 seed implantation - Open discussion following Dr. Stone's presentation, MOL UROL, 4(3), 2000, pp. 169-170
Authors:
Garnick, M
Klotz, L
Moul, J
Sylvester, J
Stone, N
Citation: M. Garnick et al., Neoadjuvant hormone therapy: The Canadian trials - Open discussion following Dr. Klotz' presentation, MOL UROL, 4(3), 2000, pp. 239-239
Authors:
Stone, N
Fair, WR
Grignon, D
Bruchovsky, N
Cookson, M
Garnick, M
Sylvester, J
Klotz, L
Zietman, A
Citation: N. Stone et al., Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer - Open discussion following Dr. Fair's presentation, MOL UROL, 4(3), 2000, pp. 249-250
Authors:
Thrasher, B
Moul, JW
Debruyne, F
Sylvester, J
Fair, W
Grignon, D
Citation: B. Thrasher et al., Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy - Open discussion following Dr. Moul's presentation, MOL UROL, 4(3), 2000, pp. 273-273
Authors:
Ginsburg, M
Adams, D
Clayton, T
Mantilla, M
Sylvester, J
Wang, YD
Citation: M. Ginsburg et al., The politics of linking educational research, policy, and practice: The case of improving educational quality in Ghana, Guatemala and Mali, INT J COMP, 41(1), 2000, pp. 27-47
Authors:
Sylvester, J
Blasko, JC
Grimm, PD
Meier, R
Goy, B
Colburn, G
Cavanagh, W
Citation: J. Sylvester et al., Neoadjuvant androgen ablation combined with external-beam radiation therapy and permanent interstitial brachytherapy boost in localized prostate cancer, MOL UROL, 3(3), 1999, pp. 231-236
Authors:
Tapen, EM
Blasko, JC
Grimm, PD
Ragde, H
Luse, R
Clifford, S
Sylvester, J
Griffin, TW
Citation: Em. Tapen et al., Reduction of radioactive seed embolization to the lung following prostate brachytherapy, INT J RAD O, 42(5), 1998, pp. 1063-1067